---
title: "康龍化成(北京)新藥技術股份有限公司 (03759.HK)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/03759.HK.md"
symbol: "03759.HK"
name: "康龍化成(北京)新藥技術股份有限公司"
industry: "生命科學工具與服務"
---

# 康龍化成(北京)新藥技術股份有限公司 (03759.HK)

| Item | Detail |
|------|--------|
| Industry | 生命科學工具與服務 |
| Location | 港股市場 |
| Website | [www.pharmaron.cn](https://www.pharmaron.cn) |

## Company Profile

藥用化合物、化學藥、生物製品、生物技術的研究與開發;提供技術開發、技術轉讓、技術咨詢、技術服務、技術培訓;貨物、技術進出口。(依法須經批准的項目,經相關部門批准後依批准的內容開展經營活動。)(以市場監督管理機關核定的經營範圍為准)

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-17T04:30:10.000Z

**Overall: B (0.36)**

**Industry**: Life Sciences Tools and Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 5 / 14 |
| Industry Median | B |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Mid - The company has stable operation of a large-cap stock and the high return of a small-cap stock.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 13.65% |  |
| Net Profit YoY | -20.54% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 2.38 |  |
| Dividend Ratio | 1.02% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 38.13B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 14.63B |  |


**Multi Score**: B

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 10.80% | B |
| Profit Margin | 11.17% | B |
| Gross Margin | 34.69% | C |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 13.65% | B |
| Net Profit YoY | -20.54% | D |
| Total Assets YoY | 7.96% | B |
| Net Assets YoY | 6.75% | B |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 895.50% | B |
| OCF YoY | 13.65% | B |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.55 | C |

#### Debt Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 41.16% | C |


```chart-data:radar
{
  "title": "Longbridge Financial Score - 康龍化成(北京)新藥技術股份有限公司",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "10.80%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "11.17%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "34.69%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "13.65%",
          "rating": "B"
        },
        {
          "name": "Net Profit YoY",
          "value": "-20.54%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "7.96%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "6.75%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "895.50%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "13.65%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.55",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "C",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "41.16%",
          "rating": "C"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | 藥明康德 (HK.2359) | A | A | C | B | B | B |
| 02 | 藥明生物 (HK.2269) | B | B | D | A | B | B |
| 03 | 藥明合聯 (HK.2268) | A | A | B | B | B | B |
| 04 | 晶泰控股 (HK.2228) | D | A | E | A | C | B |
| 05 | 康龍化成 (HK.3759) | B | B | C | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 23.02 | 3/15 | 25.81 | 20.77 | 13.48 |
| PB | 2.38 | 10/15 | 2.64 | 2.35 | 1.85 |
| PS (TTM) | 2.57 | 4/15 | 2.88 | 2.54 | 2.07 |
| Dividend Yield | 1.02% | 2/15 | 1.41% | 1.04% | 0.94% |

## Institutional View

### Analyst Rating Distribution

> As of 2026-02-04T16:00:00.000Z

Total Analysts: **14**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 10 | 71% |
| Overweight | 3 | 21% |
| Hold | 0 | 0% |
| Underweight | 0 | 0% |
| Sell | 1 | 7% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 20.84 |
| Highest Target | 46.07 |
| Lowest Target | 17.01 |

## References

- [Company Overview](https://longbridge.com/en/quote/03759.HK/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/03759.HK/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/03759.HK/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.